top of page

NEUROGENX – A Breakthrough Treatment for Neuropathy

Updated: May 29, 2022

What is neuropathy?

Neuropathy is a prevalent problem. In the U.S., over 20 million people suffer from peripheral neuropathy. Neuropathy results from damage to the nervous system. So, when nerves are damaged, for example, in our extremities, people can have symptoms that range from mild to severe and disabling. Symptoms can include tingling, burning, numbness, and pain.

What Causes Neuropathy?

Neuropathy is a common complication of diabetes. Diabetes affects almost 10% of the population in the U.S. and continues to increase every year. Diabetic polyneuropathy (DPN) is the most prevalent diabetic complication and will affect one out of two people with diabetes. DPN is a leading cause of disability due to balance disturbance, fall-related injuries, foot ulceration, and amputation. Approximately one-third of patients with DPN suffer from neuropathic pain. DPN significantly lowers an individual’s quality of life. But diabetes is not the only cause of neuropathy.

Other causes include:

  • Chemotherapy

  • Medications

  • High blood pressure

  • Heavy alcohol use

  • B12 deficiency

  • Radiculopathy

  • Illness

  • Injury

And more


Neuropathy has been extremely difficult to treat effectively, and patients must rely on a system that is interested in managing symptoms and does nothing to regenerate the dysfunctional nerves. Prescription medications, e.g., Neurontin (Gabapentin), Lyrica, anti-depressants, and opiates, are the most common answer to neuropathic symptoms. Unfortunately, many patients have to deal with the side effects of these medications.

In desperation, many patients go from doctor to doctor looking for relief, only to find their DPN continues to worsen over time. However, there is an answer, NEUROGENX. Clinical studies show that more than 4 out of 5 people who undergo this treatment experience a significant reduction in symptoms and improvement in their condition.

Neurogenx a breakthrough treatment for neuropathy

The efficacy of the NEUROGENX Treatment is due to the use of a sophisticated electronic signal. The signal has a wide frequency range that sweeps from 40,000Hz to 400Hz, and the signal’s waveform is similar to the electronic pattern (action potentials) generated by the body itself during movement. This combination of wide frequency range and electronic compatibility with the body allows the signal to reach more types of cells and nerve fibers, producing more significant benefits. Nerves are 60% more conductive than other tissue or cells. Because energy will travel the path of least resistance, most of the energy goes directly to the nerve cells, where it is most beneficial. The NEUROGENX Treatment induces change at the cellular level, increasing cellular metabolism, normalizing pH, and allowing nutrients in the cell while removing excess fluids and waste products, facilitating the healing process. The result is a reduction in neuropathy symptoms.

Are You a Candidate?

To ensure you are eligible, you would need to schedule a Neurogenx consultation. The only people who cannot be treated are…

  • Women who are pregnant

  • Individuals who have a demand-type pacemaker or defibrillator.

  • Or those who have spinal cord stimulators.

How long is each treatment, and how often does one have to get them?

Each treatment lasts 20 minutes. We typically do 2 treatments per appointment. One needs to do one to two appointments per week.

If you’re suffering with neuropathy, call Tenpenny IMC at 440-239-3438 and schedule a Neurogenx


Recommended supplements:

Omega 3s are beneficial for reducing inflammation and neuropathic pain (Okuda et al., 1996; Laubertova et al., 2017).

B vitamins have been shown to be neuroprotective and neuroregenerative (Baltrusch, 2021; Singh et al., 2014)


Baltrusch, S. (2021) The Role of Neurotropic B Vitamins in Nerve Regeneration. Biomed Research International. Received from

Boulton AJ (2015). Management of Diabetic Peripheral Neuropathy. Clin Diabetes, 23(1), 9–15.

Juster-Switlyka & Smith, A. G. (2016). Updates in diabetic peripheral neuropathy.

Published online 2016 Apr 25. DOI: 10.12688/f1000research.7898.1

Laubertová, L., Koňariková, K., Gbelcová, H., Ďuračková, Z., Muchová, J., Garaiova, I., & Žitňanová, I. (2017). Fish oil emulsion supplementation might improve quality of life of diabetic patients due to its antioxidant and anti-inflammatory properties Nutr Res, 46, 49-58. DOI: 10.1016/j.nutres.2017.07.012.

Okuda, Y., Mizutani, M., Ogawa, M., Sone, H., Asano, M., Asakura, Y., Isaka, M., Suzuki, S., Kawakami, Y., Field, J. B., & Yamashita, K. (1996). Long-term effects of eicosapentaenoic acid on diabetic peripheral neuropathy and serum lipids in patients with type II diabetes mellitus. Journal of Diabetes Complications, 10(5), 280-7. doi: 10.1016/1056-8727(95)00081-x.

Singh R, Kishore, L, & Kaur, N. (2014). Diabetic peripheral neuropathy: current perspective and future directions. Pharmacology Research, 80, 21–35.

393 views0 comments

Recent Posts

See All


bottom of page